Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a0cade92f51cbc620252e8e7b9de95e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f731a389160b4e7875bf867a64df238 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fff77eb998def188ea7dc104d32249c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61ca33de6af00b05b9717173b76abce7 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-41 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3834 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616 |
filingDate |
2012-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ef098d960f7d0ef5e68677511c95f03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3d0718d716f76872d5ae916a84037a5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f9965617f97bb71662913bd48fb1044 |
publicationDate |
2014-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2014154220-A1 |
titleOfInvention |
Methods and Compositions for Improved Tissue Regeneration by Suppression of Interferon-Gamma and Tumor Necrosis Factor-Alpha |
abstract |
The present invention discloses methods, compositions and devices for improving tissue regeneration by suppressing the effects of several proinflammatory cytokines such as TNF-α and IFN-γ. Compositions and devices of this invention will generally include one or more anti-inflammatory agent(s) capable of reducing the level of TNF-α, IFN-γ, or both. Methods for improving tissue regeneration in accordance with this invention will generally have the step of applying a composition or device of the invention to a site in need of the composition or device. Also disclosed are methods for forming composition and devices of the invention and pharmaceutical compositions comprising one or more anti-inflammatory agent(s) effective of inhibiting or reducing the levels of TNF-α, IFN-γ, or both. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019094617-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016022972-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10646518-B2 |
priorityDate |
2011-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |